Apolipoprotein J/Clusterin Prevents a Progressive Glomerulopathy of Aging

  • Rosenberg M
  • Girton R
  • Finkel D
  • et al.
98Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Apoliprotein J (apoJ)/clusterin has attracted considerable interest based on its inducibility in multiple injury processes and accumulation at sites of remodeling, regression, and degeneration. We therefore sought to investigate apoJ/clusterin's role in kidney aging, as this may reveal the accumulated effects of diminished protection. Aging mice deficient in apoJ/clusterin developed a progressive glomerulopathy characterized by the deposition of immune complexes in the mesangium. Up to 75% of glomeruli in apoJ/clusterin-deficient mice exhibited moderate to severe mesangial lesions by 21 months of age. Wild-type and hemizygous mice exhibited little or no glomerular pathology. In the apoJ/clusterin-deficient mice, immune complexes of immunoglobulin G (IgG), IgM, IgA, and in some cases C1q, C3, and C9 were detectable as early as 4 weeks of age. Electron microscopy revealed the accumulation of electron-dense material in the mesangial matrix and age-dependent formation of intramesangial tubulo-fibrillary structures. Even the most extensively damaged glomeruli showed no evidence of inflammation or necrosis. In young apoJ/clusterin-deficient animals, the development of immune complex lesions was accelerated by unilateral nephrectomy-induced hyperfiltration. Injected immune complexes localized to the mesangium of apoJ/clusterin-deficient but not wild-type mice. These results estab-lish a protective role of apoJ/clusterin against chronic glomerular kidney disease and support the hypothesis that apoJ/clusterin modifies immune complex metabolism and disposal. Apolipoprotein J (apoJ)/clusterin is a circulating glycopro-tein constitutively expressed by diverse epithelial cells. The protein is induced in injured organs in various disease states, such as Alzheimer's disease, atherosclerosis, myocardial infarc-tion, and multiple forms of acute and chronic renal disease (20, 25). Proposed functions for apoJ/clusterin include lipid trans-port, complement defense, regulation of apoptosis, membrane protection, and promotion of cell-cell interactions (25). ApoJ/ clusterin can bind a large number of macromolecules impli-cated in disease initiation and progression, including immuno-globulins and complement components. Recently clusterin has been demonstrated to function as a molecular chaperone, pre-venting denatured protein precipitation through binding to exposed hydrophobic regions and improving high-molecular-weight complex solubility (6). The structure of apoJ/clusterin has not provided much in-sight into function. Mammalian apoJ/clusterins are approxi-mately 80-kDa heterodimers (9, 16) consisting of two 40-kDa chains joined by a unique five-disulfide-bond motif (10). The protein has limited homology to other proteins and lacks clear functional motifs (9). It does contain three putative amphi-pathic ␣-helical regions, which could allow it to interact with lipids and hydrophobic regions of other proteins (6). We have recently shown that apoJ/clusterin-deficient mice exhibit enhanced inflammatory severity and sequelae in an autoimmune myocarditis model, suggesting that it can serve an anti-inflammatory role under some conditions (14). Given the marked upregulation of apoJ/clusterin that occurs in diverse tissue injury processes, it is likely that the effects of its absence in different models may reveal a variety of phenotypic features and manifestations. We hypothesized that if apoJ/clusterin played an important role in the management of inflammatory and apoptosis-associated protein complexes, there should be an accumulated effect of the failure to properly manage these proteins over time. Since free plasma protein and macromo-lecular complexes traffic through the mesangium of the kidney, this structure is particularly at risk for compromise by the absence of apoJ/clusterin. In this study, we demonstrate that the kidneys of apoJ/clusterin-deficient mice developed a pro-gressive glomerulopathy with age, characterized by mesangial expansion and the presence of deposits of immunoglobulins and complement components. These findings implicate a role for apoJ/clusterin in the long-term health of the kidney and suggest that it participates in a biochemical system for mesan-gial protection.

Cite

CITATION STYLE

APA

Rosenberg, M. E., Girton, R., Finkel, D., Chmielewski, D., Barrie, A., Witte, D. P., … Aronow, B. J. (2002). Apolipoprotein J/Clusterin Prevents a Progressive Glomerulopathy of Aging. Molecular and Cellular Biology, 22(6), 1893–1902. https://doi.org/10.1128/mcb.22.6.1893-1902.2002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free